肠康散改进肠腔给药方法治疗慢性溃疡性结肠炎临床观察

Clinical Observation of Modified Method of Intestinal Medication with ChangKang Power in Treatment of Chronic Ulerative colitis

为观察乙状结肠镜下应用肠康散治疗慢性溃疡性结肠炎的疗效，将慢性溃疡性结肠炎患者82例分为两组，治疗组42例，对照组40例。对照组用中药汤剂保留灌肠，每日1次；治疗组在乙状结肠镜下应用肠康散局部治疗，每周2次。治疗1个月后，治愈率治疗组为33．3％，对照组为22．5％；总有效率治疗组为97．6％，对照组为85．0％，治疗组优于对照组（P〈0．05）。结果表明，乙状结肠镜下局部用药治疗慢性溃疡性结肠炎的疗效优于中药保留灌肠。

For observing the therapeutic effects of ChangKang Powder under sigmoidoscopy in the treatment of chronic colitis,authors divided 78 cases into two groups.treatment group（ n = 40） and controlled group（ n =38）. Former was subjected to local treatment of ChangKang Powder under sigmoidescopy,2 times per week,Latter to retention enema with Chinese herbal drug decoction, 1 time/day. Later one month after treatment,curative rate in treatment group was 33.3%o ,while that in controlled group was 22.5%o. Total effective rate were 97.6% ,85.0% respectively and treatment group was superior to controlled group （ P 〈0.05）. Results indicates former therapy is better than latter.